BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 34805307)

  • 1. The Prognostic Value of Cardiac Biomarkers and Echocardiography in Critical COVID-19.
    Zwaenepoel B; Dhont S; Hoste E; Gevaert S; Schaubroeck H
    Front Cardiovasc Med; 2021; 8():752237. PubMed ID: 34805307
    [No Abstract]   [Full Text] [Related]  

  • 2. Association Between Angiotensin Receptor-Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction.
    Murphy SP; Prescott MF; Maisel AS; Butler J; Piña IL; Felker GM; Ward JH; Williamson KM; Camacho A; Kandanelly RR; Solomon SD; Januzzi JL
    Circ Heart Fail; 2021 Jun; 14(6):e008410. PubMed ID: 33998243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superior predictive value for NTproBNP compared with high sensitivity cTnT in dialysis patients: a pilot prospective observational study.
    Voroneanu L; Siriopol D; Nistor I; Apetrii M; Hogas S; Onofriescu M; Covic A
    Kidney Blood Press Res; 2014; 39(6):636-47. PubMed ID: 25571877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
    de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
    Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Terminal Pro B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T Levels Are Related to the Extent of Hibernating Myocardium in Patients With Ischemic Heart Failure.
    Zelt JGE; Liu PP; Erthal F; deKemp RA; Wells G; O'Meara E; Garrard L; Beanlands RSB; Mielniczuk LM
    Can J Cardiol; 2017 Nov; 33(11):1478-1488. PubMed ID: 28966019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study.
    Bosello S; De Luca G; Berardi G; Canestrari G; de Waure C; Gabrielli FA; Di Mario C; Forni F; Gremese E; Ferraccioli G
    Eur J Intern Med; 2019 Feb; 60():46-53. PubMed ID: 30366614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving Prediction of Postoperative Myocardial Infarction With High-Sensitivity Cardiac Troponin T and NT-proBNP.
    Kopec M; Duma A; Helwani MA; Brown J; Brown F; Gage BF; Gibson DW; Miller JP; Novak E; Jaffe AS; Apple FS; Scott MG; Nagele P
    Anesth Analg; 2017 Feb; 124(2):398-405. PubMed ID: 28002165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina.
    Caselli C; Prontera C; Liga R; De Graaf MA; Gaemperli O; Lorenzoni V; Ragusa R; Marinelli M; Del Ry S; Rovai D; Giannessi D; Aguade-Bruix S; Clemente A; Bax JJ; Lombardi M; Sicari R; Zamorano J; Scholte AJ; Kaufmann PA; Knuuti J; Underwood SR; Clerico A; Neglia D
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):757-64. PubMed ID: 26868212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.
    Pareek M
    Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markers of myocardial injury in the prediction of short-term COVID-19 prognosis.
    Calvo-Fernández A; Izquierdo A; Subirana I; Farré N; Vila J; Durán X; García-Guimaraes M; Valdivielso S; Cabero P; Soler C; García-Ribas C; Rodríguez C; Llagostera M; Mojón D; Vicente M; Solé-González E; Sánchez-Carpintero A; Tevar C; Marrugat J; Vaquerizo B
    Rev Esp Cardiol (Engl Ed); 2021 Jul; 74(7):576-583. PubMed ID: 33153955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac biomarkers in pediatric CKD-a prospective follow-up study.
    Lindblad YT; Vavilis G; Chromek M; Quershi AR; Löwbeer C; Bárány P
    Pediatr Nephrol; 2022 Dec; 37(12):3165-3175. PubMed ID: 35294668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic assessment of elderly patients with symptoms of heart failure by combining high-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide measurements.
    Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
    Clin Chem; 2010 Nov; 56(11):1718-24. PubMed ID: 20844063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrapartum trends of NT-proBNP and hs-cTnT in patients with severe features of preeclampsia.
    Fixler JS; Byrne JJ; Mcintire DD; Nelson DB; Gary Cunningham F
    Pregnancy Hypertens; 2024 Mar; 35():1-5. PubMed ID: 38029452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between high-sensitivity cardiac troponin T and N-terminal pro-brain natriuretic peptide in a community based population.
    Xu R; Ye P; Luo L; Sheng L; Wu H; Xiao W; Zheng J; Wang F; Xiao T
    Chin Med J (Engl); 2014; 127(4):638-44. PubMed ID: 24534215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide in acute heart failure: Data from the ACE 2 study.
    Berge K; Lyngbakken MN; Myhre PL; Brynildsen J; Røysland R; Strand H; Christensen G; Høiseth AD; Omland T; Røsjø H
    Clin Biochem; 2021 Feb; 88():30-36. PubMed ID: 33245872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unstable coronary plaque characteristics are associated with high-sensitivity cardiac troponin T and N-terminal Pro-Brain Natriuretic Peptide.
    Altintas S; Cardinaels EP; Versteylen MO; Joosen IA; Seifert M; Wildberger JE; Crijns HJ; Nelemans PJ; Van Dieijen-Visser MP; Mingels AM; Das M; Kietselaer BL
    J Cardiovasc Comput Tomogr; 2016; 10(1):82-8. PubMed ID: 26481512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of cardiac biomarkers, kidney function, and mortality among adults with chronic kidney disease.
    Claudel SE; Waikar SS; Gopal DM; Verma A
    medRxiv; 2023 Dec; ():. PubMed ID: 38168327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclinical Cardiovascular Disease in US Adults With and Without Diabetes.
    Fang M; Wang D; Tang O; McEvoy JW; Echouffo-Tcheugui JB; Christenson RH; Selvin E
    J Am Heart Assoc; 2023 Jun; 12(11):e029083. PubMed ID: 37254959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac biomarkers are associated with maximum stage of acute kidney injury in critically ill patients: a prospective analysis.
    Haines R; Crichton S; Wilson J; Treacher D; Ostermann M
    Crit Care; 2017 Apr; 21(1):88. PubMed ID: 28399905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac biomarkers on admission and in‑hospital mortality in COVID-19 patients with or without concomitant heart failure.
    Klocek M; Wojciechowska W; Terlecki M; Pavlinec C; Grodzicki T; Małecki M; Bociąga-Jasik M; Rajzer M;
    Pol Arch Intern Med; 2022 Aug; 132(7-8):. PubMed ID: 35522239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.